4.8 Article

Reciprocal modulation of long noncoding RNA EMS and p53 regulates tumorigenesis

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2111409119

关键词

p53; lncRNA; CPEB2; translation; tumorigenesis

资金

  1. Ministry of Science and Technology of China [2019YFA0802600]
  2. National Natural Science Foundation of China [91957108, 31871440]
  3. Collaborative Innovation Programs of Hefei Science Center, Chinese Academy of Sciences [2019HSC-CIP010]
  4. Fundamental Research Funds for Central Universities [YD9100002012, WK9100000024, YD2070002007]

向作者/读者索取更多资源

This study reveals a mutual repression between p53 and lncRNA E2F1 messenger RNA stabilizing factor (EMS) in tumor suppression. EMS inhibits p53 expression by disrupting the CPEB2-p53 mRNA interaction, leading to a suppression of p53 translation. EMS plays a critical role in promoting tumorigenesis through negative regulation of p53.
p53 plays a central role in tumor suppression. Emerging evidence suggests long noncoding RNA (lncRNA) as an important class of regulatory molecules that control the p53 signaling. Here, we report that the oncogenic lncRNA E2F1 messenger RNA (mRNA) stabilizing factor (EMS) and p53 mutually repress each other's expression. EMS is negatively regulated by p53. As a direct transcriptional repression target of p53, EMS is surprisingly shown to inhibit p53 expression. EMS associates with cytoplasmic polyadenylation element-binding protein 2 (CPEB2) and thus, disrupts the CPEB2-p53 mRNA interaction. This disassociation attenuates CPEB2-mediated p53 mRNA polyadenylation and suppresses p53 translation. Functionally, EMS is able to exert its oncogenic activities, at least partially, via the CPEB2-p53 axis. Together, these findings reveal a double-negative feedback loop between p53 and EMS, through which p53 is finely controlled. Our study also demonstrates a critical role for EMS in promoting tumorigenesis via the negative regulation of p53.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据